These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8898990)

  • 21. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cell proliferation at early stages of hepatocarcinogenesis.
    Schwarz M; Buchmann A; Bock KW
    Toxicol Lett; 1995 Dec; 82-83():27-32. PubMed ID: 8597064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver.
    Nejabat M; Riegler T; Reitinger T; Subosits S; Römer M; Eichner J; Bilban M; Zell A; Huber WW; Schulte-Hermann R; Grasl-Kraupp B
    Arch Toxicol; 2018 Feb; 92(2):953-966. PubMed ID: 29270806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and chemical carcinogenesis.
    Marsman DS; Barrett JC
    Risk Anal; 1994 Jun; 14(3):321-6. PubMed ID: 8029504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis.
    Rotstein J; Sarma DS; Farber E
    Cancer Res; 1986 May; 46(5):2377-85. PubMed ID: 3697980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibility of promoter induced hepatic focal lesion growth in mice.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Carcinogenesis; 1996 Jul; 17(7):1403-9. PubMed ID: 8706241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States.
    Herrero-Jimenez P; Thilly G; Southam PJ; Tomita-Mitchell A; Morgenthaler S; Furth EE; Thilly WG
    Mutat Res; 1998 May; 400(1-2):553-78. PubMed ID: 9685710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.
    Bennoun M; Rissel M; Engelhardt N; Guillouzo A; Briand P; Weber-Benarous A
    Am J Pathol; 1993 Nov; 143(5):1326-36. PubMed ID: 7694468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis.
    Bock KW; Köhle C
    Biochem Pharmacol; 2005 May; 69(10):1403-8. PubMed ID: 15857604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation and carcinogenesis models: general principles with illustrations from the rodent liver system.
    Moolgavkar SH
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):91-4. PubMed ID: 8013431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis and multistage carcinogenesis in rat liver.
    Schulte-Hermann R; Bursch W; Grasl-Kraupp B; Müllauer L; Ruttkay-Nedecky B
    Mutat Res; 1995 Dec; 333(1-2):81-7. PubMed ID: 8538639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-response of tumor formation.
    Templin MV; Constan AA; Wolf DC; Wong BA; Butterworth BE
    Carcinogenesis; 1998 Jan; 19(1):187-93. PubMed ID: 9472711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.
    Columbano A; Ledda-Columbano GM; Rao PM; Rajalakshmi S; Sarma DS
    Am J Pathol; 1984 Sep; 116(3):441-6. PubMed ID: 6476080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
    Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
    Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM; Simile MM; Feo F
    Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.